Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


27.03.2017

3 Ann Oncol
5 Ann Thorac Surg
3 Anticancer Res
1 BMJ
1 Br J Cancer
1 Cancer Chemother Pharmacol
2 Cancer Sci
3 Clin Lung Cancer
6 Eur J Cardiothorac Surg
1 Int J Cancer
5 Oncol Rep
1 PLoS Comput Biol
1 Proc Natl Acad Sci U S A
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. ZOU T, Awad MM
    More valuable than platinum: first-line pembrolizumab in advanced stage non-small cell lung cancer.
    Ann Oncol. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format    

  2. MALVEZZI M, Carioli G, Bertuccio P, Boffetta P, et al
    European cancer mortality predictions for the year 2017, with focus on lung cancer.
    Ann Oncol. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. GUBERINA M, Eberhardt W, Stuschke M, Gauler T, et al
    Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomised trial.
    Ann Oncol. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  4. CERFOLIO RJ, Bess KM, Wei B, Minnich DJ, et al
    Incidence, Results, and Our Current Intraoperative Technique to Control Major Vascular Injuries During Minimally Invasive Robotic Thoracic Surgery.
    Ann Thorac Surg. 2016;102:394-9.
    PubMed     Text format     Abstract available

  5. KENT MS, Mandrekar SJ, Landreneau R, Nichols F, et al
    Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).
    Ann Thorac Surg. 2016;102:230-8.
    PubMed     Text format     Abstract available

  6. OSAROGIAGBON RU, Decker PA, Ballman K, Wigle D, et al
    Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).
    Ann Thorac Surg. 2016;102:363-9.
    PubMed     Text format     Abstract available

  7. MARINO KA, Sullivan JL, Weksler B
    Electromagnetic Navigation Bronchoscopy for Identifying Lung Nodules for Thoracoscopic Resection.
    Ann Thorac Surg. 2016;102:454-7.
    PubMed     Text format     Abstract available

  8. AWAIS O, Reidy MR, Mehta K, Bianco V, et al
    Electromagnetic Navigation Bronchoscopy-Guided Dye Marking for Thoracoscopic Resection of Pulmonary Nodules.
    Ann Thorac Surg. 2016;102:223-9.
    PubMed     Text format     Abstract available


    Anticancer Res

  9. KASMANN L, Bolm L, Janssen S, Rades D, et al
    Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer.
    Anticancer Res. 2017;37:1535-1537.
    PubMed     Text format     Abstract available

  10. YOH K, Goto Y, Naito Y, Kishi K, et al
    Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting.
    Anticancer Res. 2017;37:1507-1513.
    PubMed     Text format     Abstract available

  11. TOYOKAWA G, Takada K, Okamoto T, Kozuma Y, et al
    Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer.
    Anticancer Res. 2017;37:1393-1401.
    PubMed     Text format     Abstract available


    BMJ


  12. Five minutes with . . . Chris Harrison, cancer tsar.
    BMJ. 2016;354:i3831.
    PubMed     Text format    


    Br J Cancer

  13. MACLEOD AK, Acosta-Jimenez L, Coates PJ, McMahon M, et al
    Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.
    Br J Cancer. 2017 Mar 21. doi: 10.1038/bjc.2017.
    PubMed     Text format    


    Cancer Chemother Pharmacol

  14. XIANG T, Kang X, Gong Z, Bai W, et al
    XPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies.
    Cancer Chemother Pharmacol. 2017;79:791-800.
    PubMed     Text format     Abstract available


    Cancer Sci

  15. KARASAKI T, Nagayama K, Kuwano H, Nitadori JI, et al
    Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Cancer Sci. 2017;108:170-177.
    PubMed     Text format     Abstract available

  16. KAMIOKA Y, Takakura K, Sumiyama K, Matsuda M, et al
    Intravital Forster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli.
    Cancer Sci. 2017;108:226-235.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  17. TAKADA K, Toyokawa G, Okamoto T, Shimokawa M, et al
    A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30047.
    PubMed     Text format     Abstract available

  18. SCHULKES KJ, Souwer ET, van Elden LJ, Codrington H, et al
    Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30049.
    PubMed     Text format     Abstract available

  19. SONG Z, Wang X, Zheng Y, Su H, et al
    MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
    Clin Lung Cancer. 2017;18:213-219.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  20. GUERRERA F, Renaud S, Tabbo F, Voegeli' AC, et al
    Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomasdagger.
    Eur J Cardiothorac Surg. 2016 Dec 15. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. HOFFERBERTH SC, Grinstaff MW, Colson YL
    Nanotechnology applications in thoracic surgery.
    Eur J Cardiothorac Surg. 2016;50:6-16.
    PubMed     Text format     Abstract available

  22. DECALUWE H, Stanzi A, Dooms C, Fieuws S, et al
    Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016;50:110-7.
    PubMed     Text format     Abstract available

  23. KIRCHEVA DY, Husain AN, Watson S, Kindler HL, et al
    Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Eur J Cardiothorac Surg. 2016;49:1642-7.
    PubMed     Text format     Abstract available

  24. STAMENOVIC D, Bostanci K, Messerschmidt A, Jahn T, et al
    Fissureless fissure-last video-assisted thoracoscopic lobectomy for all lung lobes: a better alternative to decrease the incidence of prolonged air leak?
    Eur J Cardiothorac Surg. 2016;50:118-23.
    PubMed     Text format     Abstract available

  25. WATANABE K, Tsuboi M, Sakamaki K, Nishii T, et al
    Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016;49:1624-31.
    PubMed     Text format     Abstract available


    Int J Cancer

  26. DONG J, Cheng Y, Zhu M, Wen Y, et al
    Fine Mapping of Chromosome 5p15.33 Identifies Novel Lung Cancer Susceptibility Loci in Han Chinese.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30702.
    PubMed     Text format     Abstract available


    Oncol Rep

  27. LU X, Guo H, Chen X, Xiao J, et al
    Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-beta1 in lung adenocarcinoma cells.
    Oncol Rep. 2016;36:3105-3112.
    PubMed     Text format     Abstract available

  28. KAKE S, Usui T, Ohama T, Yamawaki H, et al
    Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Oncol Rep. 2017;37:1100-1106.
    PubMed     Text format     Abstract available

  29. CHEN T, Gong W, Tian H, Wang H, et al
    Fibroblast growth factor 18 promotes proliferation and migration of H460 cells via the ERK and p38 signaling pathways.
    Oncol Rep. 2017;37:1235-1242.
    PubMed     Text format     Abstract available

  30. CHEN X, Li Q, Kan XX, Wang YJ, et al
    Extract of Caulis Spatholobi, a novel blocker targeting tumor cellinduced platelet aggregation, inhibits breast cancer metastasis.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5184.
    PubMed     Text format     Abstract available

  31. WEN R, Xiao Y, Zhang Y, Yang M, et al
    Identification of a novel transcript isoform of the TTLL12 gene in human cancers.
    Oncol Rep. 2016;36:3172-3180.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  32. GRECHKIN M, Logsdon BA, Gentles AJ, Lee SI, et al
    Identifying Network Perturbation in Cancer.
    PLoS Comput Biol. 2016;12:e1004888.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  33. MOU H, Moore J, Malonia SK, Li Y, et al
    Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis.
    Proc Natl Acad Sci U S A. 2017 Mar 20. pii: 201620861.
    PubMed     Text format     Abstract available


    Thorax

  34. MARSHALL HM, Zhao H, Bowman RV, Passmore LH, et al
    The effect of different radiological models on diagnostic accuracy and lung cancer screening performance.
    Thorax. 2017 Mar 22. pii: thoraxjnl-2016-209624.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: